Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL22345557

C[n+]1cc(CCC(=O)O)c2ccccc2n1.O=C([O-])C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 8/20 0.39
▸ PARP1 P09874 1/20 0.38
▸ PARP2 Q9UGN5 1/20 0.38
▸ FFAR4 Q5NUL3 2/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SIRT5 Q9NXA8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ KEAP1 Q14145 3/20 0.35
▸ NFE2L2 Q16236 3/20 0.35
▸ CHRM1 P11229 1/20 0.34
▸ PTGER1 P34995 1/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ PTGER3 P43115 1/20 0.34
▸ PTGER2 P43116 1/20 0.34
▸ PRNP P04156 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28634474 0.90 HDAC6 (0.46) HDAC6PARP1PARP2L3MBTL1KEAP1
Hydrochloric Acid SCHEMBL22345579 0.88 HDAC6 (0.45) HDAC6PARP1PARP2L3MBTL1KEAP1
SCHEMBL22345559 0.80 CYP4F2 (0.34) KMT2AL3MBTL1RXFP1
Trifluoroacetic Acid SCHEMBL22345475 0.78 TBXAS1 (0.34) —
Trifluoroacetic Acid SCHEMBL22345576 0.78 PKM (0.43) KMT2AL3MBTL1PRNPTSHRNPSR1
SCHEMBL22345577 0.78 HDAC6 (0.33) HDAC6PARP1PARP2PRNPTSHR
Iodide SCHEMBL22345444 0.74 KDM4E (0.46) KMT2ATSHRRXFP1
Trifluoroacetic Acid SCHEMBL29564265 0.71 BBOX1 (0.41) KMT2A
Trifluoroacetic Acid SCHEMBL28621808 0.71 BBOX1 (0.41) KMT2A
Trifluoroacetic Acid SCHEMBL28621807 0.71 BBOX1 (0.41) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
EP-3924344-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH Syngenta Crop Protection AG (CH) 2021-12-22 — — EP disclosed
WO-2020164970-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2020-08-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH NOTUM, DDT, CYP51A1 HDAC6 2293/4885PARP1 3070/4885PARP2 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback